The global market for Structural Heart Diseases Device was valued at US$ 15490 million in the year 2024 and is projected to reach a revised size of US$ 28980 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Structural heart devices comprise听annuloplasty rings, heart valve balloons occluders听among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.
The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart"s structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Structural Heart Diseases Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Diseases Device.
The Structural Heart Diseases Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Structural Heart Diseases Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Structural Heart Diseases Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
Segment by Type
CHD Occluder
Cardioembolic Stroke Occluder
Heart Valve
Other
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Structural Heart Diseases Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Structural Heart Diseases Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Structural Heart Diseases Device 麻豆原创 Overview
1.1 Product Definition
1.2 Structural Heart Diseases Device by Type
1.2.1 Global Structural Heart Diseases Device 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 CHD Occluder
1.2.3 Cardioembolic Stroke Occluder
1.2.4 Heart Valve
1.2.5 Other
1.3 Structural Heart Diseases Device by Application
1.3.1 Global Structural Heart Diseases Device 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Structural Heart Diseases Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Structural Heart Diseases Device Revenue 2020-2031
1.4.2 Global Structural Heart Diseases Device Sales 2020-2031
1.4.3 Global Structural Heart Diseases Device 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Structural Heart Diseases Device 麻豆原创 Competition by Manufacturers
2.1 Global Structural Heart Diseases Device Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Structural Heart Diseases Device Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Structural Heart Diseases Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Structural Heart Diseases Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Structural Heart Diseases Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Structural Heart Diseases Device, Product Type & Application
2.7 Global Key Manufacturers of Structural Heart Diseases Device, Date of Enter into This Industry
2.8 Global Structural Heart Diseases Device 麻豆原创 Competitive Situation and Trends
2.8.1 Global Structural Heart Diseases Device 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Structural Heart Diseases Device Players 麻豆原创 Share by Revenue
2.8.3 Global Structural Heart Diseases Device 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Structural Heart Diseases Device 麻豆原创 Scenario by Region
3.1 Global Structural Heart Diseases Device 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Structural Heart Diseases Device Sales by Region: 2020-2031
3.2.1 Global Structural Heart Diseases Device Sales by Region: 2020-2025
3.2.2 Global Structural Heart Diseases Device Sales by Region: 2026-2031
3.3 Global Structural Heart Diseases Device Revenue by Region: 2020-2031
3.3.1 Global Structural Heart Diseases Device Revenue by Region: 2020-2025
3.3.2 Global Structural Heart Diseases Device Revenue by Region: 2026-2031
3.4 North America Structural Heart Diseases Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Structural Heart Diseases Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Structural Heart Diseases Device Sales by Country (2020-2031)
3.4.3 North America Structural Heart Diseases Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Structural Heart Diseases Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Structural Heart Diseases Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Structural Heart Diseases Device Sales by Country (2020-2031)
3.5.3 Europe Structural Heart Diseases Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Structural Heart Diseases Device 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Structural Heart Diseases Device 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Structural Heart Diseases Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Structural Heart Diseases Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Structural Heart Diseases Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Structural Heart Diseases Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Structural Heart Diseases Device Sales by Country (2020-2031)
3.7.3 Latin America Structural Heart Diseases Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Structural Heart Diseases Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Structural Heart Diseases Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Structural Heart Diseases Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Structural Heart Diseases Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Structural Heart Diseases Device Sales by Type (2020-2031)
4.1.1 Global Structural Heart Diseases Device Sales by Type (2020-2025)
4.1.2 Global Structural Heart Diseases Device Sales by Type (2026-2031)
4.1.3 Global Structural Heart Diseases Device Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Structural Heart Diseases Device Revenue by Type (2020-2031)
4.2.1 Global Structural Heart Diseases Device Revenue by Type (2020-2025)
4.2.2 Global Structural Heart Diseases Device Revenue by Type (2026-2031)
4.2.3 Global Structural Heart Diseases Device Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Structural Heart Diseases Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Structural Heart Diseases Device Sales by Application (2020-2031)
5.1.1 Global Structural Heart Diseases Device Sales by Application (2020-2025)
5.1.2 Global Structural Heart Diseases Device Sales by Application (2026-2031)
5.1.3 Global Structural Heart Diseases Device Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Structural Heart Diseases Device Revenue by Application (2020-2031)
5.2.1 Global Structural Heart Diseases Device Revenue by Application (2020-2025)
5.2.2 Global Structural Heart Diseases Device Revenue by Application (2026-2031)
5.2.3 Global Structural Heart Diseases Device Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Structural Heart Diseases Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Structural Heart Diseases Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Structural Heart Diseases Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Company Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LifeTech Structural Heart Diseases Device Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Company Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lepu Medical Structural Heart Diseases Device Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Company Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Occlutech Structural Heart Diseases Device Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Company Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 W. L. Gore & Associates Structural Heart Diseases Device Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.7.1 Starway Company Information
6.7.2 Starway Description and Business Overview
6.7.3 Starway Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Starway Structural Heart Diseases Device Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Company Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Coherex Medical Structural Heart Diseases Device Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Company Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cardia Structural Heart Diseases Device Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Company Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroPort Structural Heart Diseases Device Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
6.11 Edwards Lifesciences
6.11.1 Edwards Lifesciences Company Information
6.11.2 Edwards Lifesciences Description and Business Overview
6.11.3 Edwards Lifesciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Edwards Lifesciences Structural Heart Diseases Device Product Portfolio
6.11.5 Edwards Lifesciences Recent Developments/Updates
6.12 Medtronic
6.12.1 Medtronic Company Information
6.12.2 Medtronic Description and Business Overview
6.12.3 Medtronic Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medtronic Structural Heart Diseases Device Product Portfolio
6.12.5 Medtronic Recent Developments/Updates
6.13 Venus Medtech
6.13.1 Venus Medtech Company Information
6.13.2 Venus Medtech Description and Business Overview
6.13.3 Venus Medtech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Venus Medtech Structural Heart Diseases Device Product Portfolio
6.13.5 Venus Medtech Recent Developments/Updates
6.14 Meril Life Sciences
6.14.1 Meril Life Sciences Company Information
6.14.2 Meril Life Sciences Description and Business Overview
6.14.3 Meril Life Sciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Meril Life Sciences Structural Heart Diseases Device Product Portfolio
6.14.5 Meril Life Sciences Recent Developments/Updates
6.15 Braile Biomedica
6.15.1 Braile Biomedica Company Information
6.15.2 Braile Biomedica Description and Business Overview
6.15.3 Braile Biomedica Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Braile Biomedica Structural Heart Diseases Device Product Portfolio
6.15.5 Braile Biomedica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Structural Heart Diseases Device Industry Chain Analysis
7.2 Structural Heart Diseases Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Structural Heart Diseases Device Production Mode & Process Analysis
7.4 Structural Heart Diseases Device Sales and 麻豆原创ing
7.4.1 Structural Heart Diseases Device Sales Channels
7.4.2 Structural Heart Diseases Device Distributors
7.5 Structural Heart Diseases Device Customer Analysis
8 Structural Heart Diseases Device 麻豆原创 Dynamics
8.1 Structural Heart Diseases Device Industry Trends
8.2 Structural Heart Diseases Device 麻豆原创 Drivers
8.3 Structural Heart Diseases Device 麻豆原创 Challenges
8.4 Structural Heart Diseases Device 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
听
听
*If Applicable.
